• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about RNA

Recent news which mentions RNA

< Previous 1 2 3 4 5 Next >
Avidity (RNA) Q2 Revenue Jumps 88%
August 07, 2025
Tickers RNA
Tags Market News RNA Recent Press Releases
From Motley Fool
Veritex Holdings, Sequans Communications, Canaan And Other Big Stocks Moving Higher On Monday
July 14, 2025
Tickers CAN DEFT IREN MARA
Tags NIO XYZ Movers
From Benzinga
Expert Outlook: Avidity Biosciences Through The Eyes Of 11 Analysts
June 27, 2025
Tickers RNA
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
The Analyst Verdict: Avidity Biosciences In The Eyes Of 12 Experts
June 10, 2025
Tickers RNA
Tags Benzinga RNA BZI/AAR
From Benzinga
Avidity Biosciences Touts Encouraging Functional Gains And Biomarker Reductions In Rare Muscular Weakness Disease Trial
June 09, 2025
Tickers NEWS RNA
Tags Movers Stories That Matter Briefs
From Benzinga
12 Analysts Assess Avidity Biosciences: What You Need To Know
May 07, 2025
Tickers RNA
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Beyond The Numbers: 13 Analysts Discuss Avidity Biosciences Stock
April 09, 2025
Tickers RNA
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
Forecasting The Future: 13 Analyst Projections For Avidity Biosciences
March 18, 2025
Tickers RNA
Tags RNA Benzinga BZI/AAR
From Benzinga
Avidity Biosciences Touts Positive Data From Early-Stage Duchenne Muscular Dystrophy Study Data, FDA Submission Expected By End Of 2025
March 17, 2025
Tickers NEWS RNA
Tags Market News News RNA
From Benzinga
Dyne Therapeutics' $4.3 Billion Peak Sales Potential? Analyst Highlights Key Strengths And Risks
March 12, 2025
Tickers DYN NEWS RNA
Tags Equities RNA Benzinga
From Benzinga
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
March 12, 2025
Tickers NEWS RADX RNA SPGI
Tags TLN RNA Top Initiations
From Benzinga
Avidity Biosciences Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
February 28, 2025
Tickers RNA
Tags Benzinga RNA BZI/AAR
From Benzinga
Analyst Expectations For Avidity Biosciences's Future
January 10, 2025
Tickers RNA
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic
January 03, 2025
Tickers ALNY BIIB DNLI IONS
Tags Analyst Ratings RNA Benzinga
From Benzinga
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
December 20, 2024
Tickers FICO MNKD NEWS PRTA
Tags RNA Top Initiations Benzinga
From Benzinga
What 8 Analyst Ratings Have To Say About Avidity Biosciences
December 20, 2024
Tickers RNA
Tags RNA Benzinga Analyst Ratings
From Benzinga
Assessing Avidity Biosciences: Insights From 10 Financial Analysts
November 13, 2024
Tickers RNA
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
In-Depth Examination Of 10 Analyst Recommendations For Avidity Biosciences
October 21, 2024
Tickers RNA
Tags RNA Benzinga BZI/AAR
From Benzinga
Evaluating Avidity Biosciences: Insights From 10 Financial Analysts
October 21, 2024
Tickers RNA
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 07, 2024
Tickers CUE IMNM KAPA LGMK
Tags Market News OGEN BZI/TFM
From Benzinga
Why Avidity Biosciences Zoomed to a 12% Gain This Week
October 04, 2024
Tickers GS RNA
Tags Market News GS RNA
From Motley Fool
Goldman Sachs Bullish On Avidity Biosciences, Cites Scalable RNA Therapeutics Platform For Rare Diseases
September 24, 2024
Tickers NEWS RNA
Tags Price Target General News
From Benzinga
Unveiling 7 Analyst Insights On Avidity Biosciences
September 16, 2024
Tickers RNA
Tags RNA Benzinga Analyst Ratings
From Benzinga
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
September 09, 2024
Tickers FULC NEWS RHHBY RNA
Tags Analyst Color Biotech Expert Ideas
From Benzinga
Deep Dive Into Avidity Biosciences Stock: Analyst Perspectives (10 Ratings)
August 28, 2024
Tickers RNA
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
The Analyst Landscape: 7 Takes On Avidity Biosciences
August 12, 2024
Tickers RNA
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
RNA Stock Earnings: Avidity Biosciences Beats EPS, Misses Revenue for Q2 2024
August 09, 2024
Tickers RNA
Tags Earnings Reports RNA Market News
From InvestorPlace
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
August 09, 2024
Tickers ADMA AKAM BLND CARG
Tags ADMA RNA Benzinga
From Benzinga
3 Stocks Doing Even Better Than Superstar Super Micro (SMCI)
July 24, 2024
Tickers AMZN JMIA MSTR NVDA
Tags MSTR BTC/USD Stocks to Buy
From InvestorPlace
3 Russell 2000 Growth Stocks That Could Be Worth the Risk
July 23, 2024
Tickers LBPH RNA SOUN
Tags Market News SOUN Recent Press Releases
From Motley Fool
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap